Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Share-based Compensation (2016 - 2020)

Historic Share-based Compensation for Larimar Therapeutics (LRMR) over the last 8 years, with Q4 2020 value amounting to $1.0 million.

  • Larimar Therapeutics' Share-based Compensation rose 338275.86% to $1.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $2.2 million, marking a year-over-year decrease of 41.47%. This contributed to the annual value of $8.8 million for FY2024, which is 1550.89% up from last year.
  • Latest data reveals that Larimar Therapeutics reported Share-based Compensation of $1.0 million as of Q4 2020, which was up 338275.86% from $370000.0 recorded in Q3 2020.
  • Larimar Therapeutics' Share-based Compensation's 5-year high stood at $2.9 million during Q2 2016, with a 5-year trough of $29000.0 in Q4 2019.
  • Moreover, its 5-year median value for Share-based Compensation was $2.1 million (2017), whereas its average is $1.6 million.
  • Per our database at Business Quant, Larimar Therapeutics' Share-based Compensation plummeted by 9876.45% in 2019 and then soared by 338275.86% in 2020.
  • Quarter analysis of 5 years shows Larimar Therapeutics' Share-based Compensation stood at $2.0 million in 2016, then grew by 4.73% to $2.1 million in 2017, then rose by 8.94% to $2.3 million in 2018, then tumbled by 98.73% to $29000.0 in 2019, then skyrocketed by 3382.76% to $1.0 million in 2020.
  • Its Share-based Compensation stands at $1.0 million for Q4 2020, versus $370000.0 for Q3 2020 and $752000.0 for Q2 2020.